It is now well established that digoxin is an effective drug for the treatment of heart failure. Since treatment with angiotensin-converting enzyme (ACE) inhibitors reduces mortality in congestive heart failure, digoxin should be added to ACE inhibitors in patients with moderate or severe heart failure. The beneficial effects of digoxin may be due, in part, to its well-documented sympathoinhibitory effects that can avert the adverse effects of long-term excessive sympathetic adrenergic stimulation in heart failure.
KannelW.Epidemiological aspects of heart failure.Cardiol Clin7: 1, 1989
2.
The SOLVD investigators.Effect of enalapril on survival in patients with reduced left ventricular function and congestive heart failure.N Engl J Med325: 293, 1991
3.
The CONSENSUS Trial Study Group.Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).N Engl J Med316: 1429, 1987
4.
CohnJ.N., JohnsonG., ZietscheS. for the Vasodilator-Heart Failure Veterans Administration Cooperative Study Group. A comparison of enalapril with hydralazin-isosorbid dinitrate in the treatment of chronic congestive heart failure.N Engl J Med325: 303, 1991
5.
CIBIS Investigators.A randomized trial of beta blockade in heart failure: the cardiac insufficiency bisoprolol study.Circulation90: 1765, 1994
6.
PackerM., BristowM.R., CohnJ.N., ColucciW.S., FowlerM.B., GilbertE.G.Effect of carvedilol on the survival of patients with chronic heart failure (Abst).Circulation92: I-142, 1996
7.
MarcusF.Digoxin is effective, but is it safe?Cardiovasc Drug Ther7: 893, 1993
8.
The German and Austrian Xamoterol Study Group.Double-blind, placebo-controlled comparison of digoxin and xamoterol in chronic heart failure.Lancet1: 489, 1988
9.
Captopril Digoxin Multicenter Study Group.Comparison of effects of treatment with captopril and digoxin in patients with mild to moderate heart failure.JAMA259: 539, 1988
10.
Di BiancoR.D., ShabetaiR., KostukW., MoranJ., SchlantR.C., WrightR. (for the Milrinone Multicenter Trial Group). A comparison of oral milrinone, digoxin and their combination in the treatment of patients with chronic heart failure.N Engl J Med320: 677, 1989
11.
JaeschkeR., OxmanA.D., GuyattG.H.To what extent do congestive heart failure patients in sinus rhythm benefit from digoxin therapy? A systematic overview and meta analysis.Am J Med88: 279, 1990
12.
UretskyB.F., YoungJ.B., ShahidiF.E., YellenL.G., HarrisonM.C., JollyM.K.Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial.PROVED Investigative Group. J Am Coll Cardiol22: 955, 1993
13.
HeckI., MuellerH.M., EsserH., LuederitzB.A comparison of captopril and digoxin in the treatment of mild to moderate severe heart failure.Deutsch Med Wschr114: 695, 1989
14.
BeauneJ. (for the Enalapril versus Digoxin French Multi-center Study Group). Comparison of enalapril versus digoxin for congestive heart failure.Am J Cardiol63: 22D, 1989
15.
DaviesR.F., BeanlandsD.S., NadeauC. (for the Canadian Enalapril versus Digoxin Study Group). Enalapril versus digoxin in patients with congestive heart failure: a multi-center study.J Am Coll Cardiol18: 1601, 1991
16.
HerlitzJ. (on behalf of the Lisinopril-Digoxin Study Group). Comparison of lisinopril versus digoxin for congestive heart failure during maintenance diuretic therapy.Am J Cardiol70: 84C, 1992
17.
PackerM., GheorghiadeM., YoungJ.B. (for the RADIANCE Study Group). Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.N Engl J Med329: 1, 1993
18.
MarcusF.I.Digitalis. In SchlantR.C., AlexanderR., (eds). Hurst's The Heart: Arteries and Veins (ed 8), McGraw HillNew York, pp. 573–588, 1994
19.
EwyG.A., KapadiaG.G., YaoL., LullinM., MarcusF.I.Digoxin metabolism in the elderly.Circulation39: 449, 1969
20.
The Xamoterol in Severe Heart Failure Study Group.Xamoterol in severe heart failure.Lancet336: 1, 1990
21.
PackerM., CaverJ.R., RodehefferR.J.Effect of oral milrinone on mortality in severe chronic heart failure.N Engl J Med325: 1468, 1991
22.
UretskyB.T., JessupM., KonstamM.A. (for the Enoximone Multicenter Trial Group). Multicenter trail of oral enoximone in patients with moderate and moderately severe congestive heart failure: lack of benefit compared to placebo.Circulation82: 774, 1990
BiggerJ.T.Jr., FleissJ.L., RolnitzkyL.M., MerabJ.P., FerrikK.J.Effects of digitalis treatment on survival after acute myocardial infarction.Am J Cardiol55: 623, 1985
25.
ByingtonR., GoldsteinS. (for the BHAT Research Group).Association of digitalis therapy with mortality in survivors of acute myocardial infarction: observations in the Beta Blocker Heart Attack Trial.J Am Coll Cardiol6: 976, 1985
26.
MullerJ., TuriZ., StoneP.H. (and the MILIS Study Group) Digoxin therapy and mortality after myocardial infarction: experience in the MILIS study.N Engl J Med314: 265, 1986
27.
The Digitalis Subcommittee of the Multicenter Postinfarction Research Group.The mortality risk associated with digitalis treatment after myocardial infarction.Cardiovasc Drugs Ther1: 125, 1987
28.
LeorJ., GoldbourtU., BeharS., BoykoV., Reichter-ReissH., KaplinskyE., RabinovitzB. (and the SPRINT Study Group). Digoxin and mortality in survivors of acute myocardial infarction: observations in patients at low and intermediate risk.Cardiovasc Drugs Ther9: 609, 1995
29.
LeorJ., GoldbourtU., RabinovitzB., Reichter-ReissH., BoykoV., KaplinskyE., BeharS. (and the SPRINT Study Group). Digoxin and increased mortality among patients recovering from acute myocardial infarction: importance of digoxin dose.Cardiovasc Drugs Ther9: 723, 1995
30.
ManciniD.M., BenottiJ.R., ElkayamU. (for the PROMISE Investigators and Coordinators). Antiarrhythmic drug use and serum levels of digitalis are independent prognostic factors in patients with chronic heart failure (Abst).Circulation84: II243, 1991
31.
The CAST Investigators.Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.N Engl J Med321: 406, 1989
32.
PrescottL.Digoxin worthy of addition to ACEIs and diuretics in CHF.Inpharma no1032: 13–14, 1996
33.
SmithT.W.Digitalis: mechanisms of action and clinical use.N Engl J Med318: 358, 1988
CohnJ.N., LevineT.B., OlivariM.T.Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure.N Engl J Med311: 819, 1984
36.
GrassiG., ServalleG., CattanoB.Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure.Circulation92: 3206, 1995
37.
HirschA.T., DzauV.J., CreagerM.A.Baroreceptor function in congestive heart failure: effect on neurohormonal activation and regional vascular resistance.Circulation75 (suppl): IV36, 1987
38.
ReichenbachD.D., BenditE.P.Catecholamines and cardiomyopathy: the pathogenesis and potential importance of myofibrillar degeneration.Hum Pathol1: 125, 1970
39.
MannD.L., KentR.L., ParsonsB., CooperG.I.V.Adrenergic effects on the biology of the adult mammalian cardiocyte.Circulation85: 790, 1992
40.
BristowM.R., GinsbergR., FowlerM.Beta 1 and beta 2 receptor subpopulations in normal and failing human ventricular myocardium: coupling of both receptor types to muscle contraction and selective beta 1 receptor down-regulation in heart failure.Circ Res59: 297, 1986
41.
RibnerH.S., PulcinskiA.D., HsiehA.M.Acute effects of digoxin on total vascular resistance in congestive heart failure due to dilated cardiomyopathy: a hemodynamic–neurohormonal study.Am J Cardiol56: 896, 1985
42.
GheorghiadeM., HallV., LakierJ.B., GoldsteinS.Comparative hemodynamic and neurohormonal effects of intravenous captopril and digoxin and their combinations in patients with severe heart failure.J Am Coll Cardiol13: 134, 1989
43.
KrumH., BiggerJ.T., GoldsmithR.L., PackerM.Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failure.J Am Coll Cardiol25: 289, 1995
44.
BrouwerJ., Van VeldhuisenD.J., Man in ‘t VeldA.J., DunselmanP.H.J.M., BoomsmaF., HaaksmaJ., LieK.I. (for the DIMT Study Group). Heart rate variability in patients with mild to moderate heart failure: effects of neurohormonal modulation by digoxin and ibopamine.J Am Coll Cardiol26: 983, 1995
45.
FergusonD.W., BergW.J., SandersJ.S., RoachP.J., KempfJ.S., KienzleM.G.Sympathoinhibitory response to digitalis glycosides in heart failure patients.Circulation80: 65, 1989
46.
FergusonD.W., AbboudF.M., MarkA.L.Selective impairment of baroreflex mediated vasoconstrictor response in patients with ventricular dysfunction.Circulation69: 451, 1984
47.
The SOLVD Investigators.Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction.N Engl J Med327: 685, 1992
48.
YoungJ.B., GheorghiadeM., PackerM., UretskyB., HullH., (on behalf of the PROVED and RADIANCE Investigators) Are low serum levels of digoxin effective in chronic heart failure? Evidence challenging the accepted guidelines for a therapeutic serum level of the drug (Abst).J Am Coll Cardiol21: 376A, 1993
